METTLER-TOLEDO INTERNATIONAL (MTD)

US5926881054 - Common Stock

1230.74  +24.72 (+2.05%)

After market: 1230.74 0 (0%)

Fundamental Rating

5

Taking everything into account, MTD scores 5 out of 10 in our fundamental rating. MTD was compared to 56 industry peers in the Life Sciences Tools & Services industry. MTD has an excellent profitability rating, but there are some minor concerns on its financial health. MTD has a valuation in line with the averages, but on the other hand it scores bad on growth.



9

1. Profitability

1.1 Basic Checks

MTD had positive earnings in the past year.
In the past year MTD had a positive cash flow from operations.
Each year in the past 5 years MTD has been profitable.
In the past 5 years MTD always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 23.97%, MTD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
MTD has a better Return On Invested Capital (40.43%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 9.98%.
The last Return On Invested Capital (40.43%) for MTD is above the 3 year average (39.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 23.97%
ROE N/A
ROIC 40.43%
ROA(3y)23.87%
ROA(5y)22.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.06%
ROIC(5y)35.9%

1.3 Margins

Looking at the Profit Margin, with a value of 21.15%, MTD belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
In the last couple of years the Profit Margin of MTD has grown nicely.
With an excellent Operating Margin value of 28.24%, MTD belongs to the best of the industry, outperforming 98.21% of the companies in the same industry.
MTD's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 59.48%, MTD belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.24%
PM (TTM) 21.15%
GM 59.48%
OM growth 3Y3.43%
OM growth 5Y4%
PM growth 3Y2.15%
PM growth 5Y3.58%
GM growth 3Y0.45%
GM growth 5Y0.61%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MTD is creating value.
MTD has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MTD has been reduced compared to 5 years ago.
Compared to 1 year ago, MTD has a worse debt to assets ratio.

2.2 Solvency

MTD has an Altman-Z score of 10.10. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
MTD's Altman-Z score of 10.10 is amongst the best of the industry. MTD outperforms 92.86% of its industry peers.
MTD has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as MTD would need 2.34 years to pay back of all of its debts.
MTD's Debt to FCF ratio of 2.34 is amongst the best of the industry. MTD outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.34
Altman-Z 10.1
ROIC/WACC3.5
WACC11.55%

2.3 Liquidity

A Current Ratio of 1.01 indicates that MTD should not have too much problems paying its short term obligations.
MTD has a worse Current ratio (1.01) than 87.50% of its industry peers.
MTD has a Quick Ratio of 1.01. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
MTD's Quick ratio of 0.69 is on the low side compared to the rest of the industry. MTD is outperformed by 94.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.69

3

3. Growth

3.1 Past

MTD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.45%.
Measured over the past years, MTD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.34% on average per year.
Looking at the last year, MTD shows a decrease in Revenue. The Revenue has decreased by -3.80% in the last year.
The Revenue has been growing slightly by 5.23% on average over the past years.
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y13.34%
EPS Q2Q%4.18%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y5.23%
Sales Q2Q%1.28%

3.2 Future

The Earnings Per Share is expected to grow by 10.35% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.82% on average over the next years.
EPS Next Y7.62%
EPS Next 2Y5.96%
EPS Next 3Y7.88%
EPS Next 5Y10.35%
Revenue Next Year0.81%
Revenue Next 2Y1.83%
Revenue Next 3Y3.11%
Revenue Next 5Y3.82%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

MTD is valuated quite expensively with a Price/Earnings ratio of 32.26.
MTD's Price/Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 75.00% of the companies in the same industry.
MTD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 28.79, MTD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTD indicates a somewhat cheap valuation: MTD is cheaper than 69.64% of the companies listed in the same industry.
MTD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.26
Fwd PE 28.79

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than 76.79% of the companies in the same industry.
MTD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MTD is cheaper than 80.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.22
EV/EBITDA 23.6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)4.24
PEG (5Y)2.42
EPS Next 2Y5.96%
EPS Next 3Y7.88%

0

5. Dividend

5.1 Amount

MTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (12/20/2024, 10:18:38 PM)

After market: 1230.74 0 (0%)

1230.74

+24.72 (+2.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)01-02 2025-01-02/amc
Inst Owners98.96%
Inst Owner Change-1.86%
Ins Owners0.4%
Ins Owner Change1.37%
Market Cap25.97B
Analysts52.38
Price Target1375.74 (11.78%)
Short Float %1.56%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.39%
Min EPS beat(2)1.02%
Max EPS beat(2)5.75%
EPS beat(4)3
Avg EPS beat(4)3.51%
Min EPS beat(4)-7.89%
Max EPS beat(4)15.16%
EPS beat(8)6
Avg EPS beat(8)2.2%
EPS beat(12)10
Avg EPS beat(12)3.1%
EPS beat(16)14
Avg EPS beat(16)4.27%
Revenue beat(2)2
Avg Revenue beat(2)0.46%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-3.41%
Max Revenue beat(4)4.21%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)9
Avg Revenue beat(12)0.31%
Revenue beat(16)13
Avg Revenue beat(16)1.12%
PT rev (1m)-3.91%
PT rev (3m)-3.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.14%
EPS NY rev (1m)0.48%
EPS NY rev (3m)0.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 32.26
Fwd PE 28.79
P/S 6.9
P/FCF 29.22
P/OCF 26.4
P/B N/A
P/tB N/A
EV/EBITDA 23.6
EPS(TTM)38.15
EY3.1%
EPS(NY)42.75
Fwd EY3.47%
FCF(TTM)42.11
FCFY3.42%
OCF(TTM)46.62
OCFY3.79%
SpS178.3
BVpS-7.32
TBVpS-51.62
PEG (NY)4.24
PEG (5Y)2.42
Profitability
Industry RankSector Rank
ROA 23.97%
ROE N/A
ROCE 49.76%
ROIC 40.43%
ROICexc 41.83%
ROICexgc 76.5%
OM 28.24%
PM (TTM) 21.15%
GM 59.48%
FCFM 23.62%
ROA(3y)23.87%
ROA(5y)22.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.06%
ROIC(5y)35.9%
ROICexc(3y)40.66%
ROICexc(5y)37.86%
ROICexgc(3y)73.64%
ROICexgc(5y)66.69%
ROCE(3y)48.08%
ROCE(5y)44.19%
ROICexcg growth 3Y10.23%
ROICexcg growth 5Y5.45%
ROICexc growth 3Y6.66%
ROICexc growth 5Y4.94%
OM growth 3Y3.43%
OM growth 5Y4%
PM growth 3Y2.15%
PM growth 5Y3.58%
GM growth 3Y0.45%
GM growth 5Y0.61%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.34
Debt/EBITDA 1.6
Cap/Depr 77.26%
Cap/Sales 2.53%
Interest Coverage 250
Cash Conversion 82.98%
Profit Quality 111.68%
Current Ratio 1.01
Quick Ratio 0.69
Altman-Z 10.1
F-Score6
WACC11.55%
ROIC/WACC3.5
Cap/Depr(3y)97.91%
Cap/Depr(5y)99.43%
Cap/Sales(3y)2.92%
Cap/Sales(5y)3%
Profit Quality(3y)99.29%
Profit Quality(5y)98.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y13.34%
EPS Q2Q%4.18%
EPS Next Y7.62%
EPS Next 2Y5.96%
EPS Next 3Y7.88%
EPS Next 5Y10.35%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y5.23%
Sales Q2Q%1.28%
Revenue Next Year0.81%
Revenue Next 2Y1.83%
Revenue Next 3Y3.11%
Revenue Next 5Y3.82%
EBIT growth 1Y-8.61%
EBIT growth 3Y10.75%
EBIT growth 5Y9.44%
EBIT Next Year8.7%
EBIT Next 3Y6.36%
EBIT Next 5Y7.1%
FCF growth 1Y32.72%
FCF growth 3Y10.83%
FCF growth 5Y15.3%
OCF growth 1Y23.49%
OCF growth 3Y10.05%
OCF growth 5Y11.32%